HIGHLIGHTS
- who: Report and collaborators from the Internal Medicine, University of Connecticut School of Medicine, Farmington, USA Cardiology, Hospital have published the research: Review began 11/16/2021 Review ended 02/17/2022 Published 02/21/2022 © Copyright, in the Journal: (JOURNAL) of February/21,/2022
- what: Over the course of the last decade, cardiac amyloidosis has undergone a transition from a rare, underdiagnosed terminal disease with no established treatment to a more common, treatable condition; hence, in this study, the authors aimed to highlight the importance of heightened clinical suspicion, prompt diagnosis, and treatment of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.